α-Synuclein in Parkinson’s disease: causal or bystander?
Peter Riederer(University of Southern Denmark), Camelia‐Maria Monoranu(University of Würzburg), Wolfgang H. Jost(Johannes Gutenberg University Mainz), Jürgen Winkler(Friedrich-Alexander-Universität Erlangen-Nürnberg), Heinz Reichmann(TU Dresden), Christian Dresel, Alexander Storch(German Center for Neurodegenerative Diseases), Thomas Müller(Ruhr University Bochum), Fubo Cheng(Jilin University), Nicolas Casadei(Bernstein Center for Computational Neuroscience Tübingen), Friederike Zunke(Friedrich-Alexander-Universität Erlangen-Nürnberg), Olaf Rieß(University Children's Hospital Tübingen), Thilo van Eimeren(University of Cologne), Ullrich Wüllner(University of Bonn), Konstanze F. Winklhofer(Unknown), Joseph Claßen(Leipzig University), Hans‐Ullrich Völker(Leopoldina Krankenhaus Schweinfurt), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Rejko Krüger(Centre Hospitalier de Luxembourg), Sabrina Strobel(University of Würzburg)
Cited by 114
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k